Results 171 to 180 of about 121,678 (291)
Pathogenesis and treatment of obesity-related polycystic ovary syndrome. [PDF]
J Ovarian ResOuyang X, Zhou Q, Tang H, Li L.
europepmc +1 more source
β-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome [PDF]
, 2005 Mark O. Goodarzi +4 more
openalex +1 more source
Van Wyk–Grumbach Syndrome With Insulin Resistance in Children: A Case Report
Clinical Case Reports, Volume 13, Issue 12, December 2025.Brain magnetic resonance imaging (MRI) at diagnosis and after 3 months of levothyroxine replacement. ABSTRACT This case reports an 8 year‐5 month‐old girl diagnosed with Van Wyk–Grumbach Syndrome (VWGS) and co‐existing insulin resistance from China. The patient achieved complete resolution of clinical manifestations with thyroid hormone replacement ...
Hui Liu +5 more
wiley +1 more source
The Endocrinological Basis for Polycystic Ovary Syndrome: An Evolutionary Perspective. [PDF]
EndocrinologyDumesic DA +3 more
europepmc +1 more source
Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview [PDF]
, 2012 Ghina Ghazeeri +3 more
openalex +1 more source
Effect of Sleeve Gastrectomy on Kisspeptin Expression in the Hypothalamus of Rats with Polycystic Ovary Syndrome [PDF]
, 2020 openalex +1 more source
Clinical Case Reports, Volume 13, Issue 12, December 2025.ABSTRACT Hypopigmented mycosis fungoides (HMF) is a variant of mycosis fungoides (MF). It is classified as a low‐grade lymphoproliferative disorder and is often challenging to diagnose, especially in young, darker‐skinned patients, due to its resemblance to benign conditions such as pityriasis alba, idiopathic macular hypomelanosis (IMH), parapsoriasis,
Ravi Das +5 more
wiley +1 more source
Hippo signaling pathway in polycystic ovary syndrome. [PDF]
Front Endocrinol (Lausanne)Wen J, Cheng G, Zhang Y, Liu S.
europepmc +1 more source